Characterization of pSer129-αSyn Pathology and Neurofilament Light-Chain Release across In Vivo, Ex Vivo, and In Vitro Models of Pre-Formed-Fibril-Induced αSyn Aggregation

Maja L. Hansen,Malene Ambjørn,Mikkel N. Harndahl,Tau Benned-Jensen,Karina Fog,Kaare Bjerregaard-Andersen,Florence Sotty
DOI: https://doi.org/10.3390/cells13030253
IF: 6
2024-01-30
Cells
Abstract:Protein aggregation is a predominant feature of many neurodegenerative diseases, including synucleinopathies, which are characterized by cellular inclusions containing α-Synuclein (αSyn) phosphorylated at serine 129 (pSer129). In the present study, we characterized the development of αSyn pre-formed fibril (PFF)-induced pSer129-αSyn pathology in F28tg mice overexpressing human wild-type αSyn, as well as in ex vivo organotypic cultures and in vitro primary cultures from the same mouse model. Concurrently, we collected cerebrospinal fluid (CSF) from mice and conditioned media from ex vivo and in vitro cultures and quantified the levels of neurofilament light chain (NFL), a biomarker of neurodegeneration. We found that the intra-striatal injection of PFFs induces the progressive spread of pSer129-αSyn pathology and microglial activation in vivo, as well as modest increases in NFL levels in the CSF. Similarly, PFF-induced αSyn pathology occurs progressively in ex vivo organotypic slice cultures and is accompanied by significant increases in NFL release into the media. Using in vitro primary hippocampal cultures, we further confirmed that pSer129-αSyn pathology and NFL release occur in a manner that correlates with the fibril dose and the level of the αSyn protein. Overall, we demonstrate that αSyn pathology is associated with NFL release across preclinical models of seeded αSyn aggregation and that the pharmacological inhibition of αSyn aggregation in vitro also significantly reduces NFL release.
cell biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the relationship between α - Synuclein (αSyn) aggregation and Neurofilament Light Chain (NFL) release by studying the pathological changes induced by α - Synuclein (αSyn) pre - formed fibrils (PFF). Specifically, the authors characterized the PFF - induced pSer129 - αSyn pathological features and NFL release in in vivo, ex vivo and in vitro models to evaluate the impact of αSyn aggregation on neurodegenerative responses and explore the potential of NFL as a biomarker for neurodegenerative diseases. ### Research Background α - Synuclein (αSyn) is an aggregation - prone protein, mainly existing in the cytoplasm of neurons and oligodendrocytes, and is a标志性成分 of multiple neurodegenerative diseases (such as Parkinson's disease and multiple system atrophy). A common feature of these diseases is the formation of inclusions containing pSer129 - αSyn in cells. The aggregation of αSyn can spread from one cell to another like a prion, accelerating the progress of the disease. ### Research Objectives 1. **Characterize the pathological features of αSyn aggregation**: By injecting PFFs into F28tg mice (a mouse model overexpressing human wild - type αSyn), study how PFFs induce the pathological features of pSer129 - αSyn and its spread in different brain regions. 2. **Evaluate NFL release**: Collect the cerebrospinal fluid (CSF) of mice and the conditioned media from ex vivo and in vitro cultures, and quantitatively analyze NFL levels to evaluate the degree of neurodegeneration. 3. **Explore the relationship between αSyn aggregation and NFL release**: By observing the relationship between αSyn aggregation and NFL release in different models, verify whether NFL can be used as a biomarker for neurodegenerative diseases. ### Main Findings - **In vivo model**: Injection of PFFs led to the gradual spread of pSer129 - αSyn pathological features and activation of microglia, while the NFL level in CSF also increased. - **Ex vivo model**: In ex vivo organ slice cultures, the αSyn pathological features induced by PFFs gradually developed, accompanied by significant NFL release. - **In vitro model**: In primary hippocampal cultures, the pSyn129 - αSyn pathological features and NFL release induced by PFFs were related to the fiber dose and αSyn protein level. ### Conclusion There is a close relationship between αSyn aggregation and NFL release, indicating that NFL can be used as a sensitive biomarker to evaluate the timing and severity of neurodegenerative responses caused by αSyn aggregation in different models. In addition, pharmacological inhibition of αSyn aggregation can also significantly reduce NFL release, which provides a theoretical basis for further development of treatment strategies.